About Small Pharma
Small Pharma is a Healthcare company based in London (United Kingdom) founded in 2015, and was acquired by Cybin in August 2023. Psychedelic-based therapeutics for mental health conditions are developed. Small Pharma has raised $49.17 million across 7 funding rounds from investors including Gov.uk, Canaccord Genuity Group and Cybin. The company has 9 employees. Small Pharma was last valued at $4.19 million in July 2019. Small Pharma offers products and services including CYB003 and CYB004. Its focus areas include Life Sciences, Neurology, Drugs and Psychiatric. Its legal entity is SMALL PHARMA LTD.
Company details
Small Pharma was founded in 2015 in London, United Kingdom. Psychedelic-based therapeutics targeting mental health conditions are developed within the biotechnology sector. Tryptamine-based drug candidates are formulated using proprietary deuterium enriching technology. Operations center on advancing the pipeline, which includes SPL026, SPL028, SPL029, and SPL801 as injectable and oral DMT therapies for depressive disorder.
- Annual Revenue$58.28 K (USD)-52as on Feb 28, 2021
- Net Profit-$13.74 M (USD)-145as on Feb 28, 2022
- EBITDA-$14.26 M (USD)-155as on Feb 28, 2022
- Total Equity Funding$49.17M (USD)
in 7 rounds
- Latest Funding Round$46.02M (USD), Series A
Mar 2021
- InvestorsGov.uk
& 8 more
- Employee Count9
- Acquired byCybin
(Aug 2023)
Products & Services of Small Pharma
Small Pharma offers a comprehensive portfolio of products and services, including CYB003 and CYB004.
Targets Major Depressive Disorder through psychedelic innovation
Addresses Generalized Anxiety Disorder via novel formulations
Funding Insights of Small Pharma
Small Pharma has successfully raised a total of $49.17M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $46.02 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.17M
- Total Rounds 7
- Last Round Series A β $46.02M
- First Round $125,666
(Aug 2015)
- Investors Count 8
All 7 funding rounds of Small Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $46.02M | Series A | β | Canaccord Genuity Group, Eight Capital | β |
| Jul 2019 | $911,679 | Seed | $4.19M | AI Fund, o2h ventures | β |
| Dec 2018 | $197,215 | Seed | $3.37M | β | β |
| Apr 2017 | $884,896 | Angel Round | β | Chris Torrance | |
| Apr 2017 | $173,909 | Grant | β | β | |
| Feb 2017 | $1.03M | Seed | $β’β’β’β’β’ | β | β |
| Aug 2015 | $125,666 | Seed | $β’β’β’β’β’ | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Jul 2019 | $4.19M | β’β’β’β’β’β’β’β’ |
| Dec 2018 | $3.37M | β’β’β’β’β’β’β’β’ |
| Feb 2017 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
| Aug 2015 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Small Pharma
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $4.19M (Jul 2019). 9 investors in total: 7 institutional and 2 angel.
Investors in Small Pharma
Small Pharma has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Gov.uk, Canaccord Genuity Group and Cybin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AI Fund is operated as a venture studio for AI startups. | aifund.ai | Mountain View, United States | ||
Venture capital firm focused on angel investments | acfinvestors.com | Sheffield, United Kingdom | ||
| eight.capital | ||||
Invests in biotech therapeutics and AI technologies through EIS funds. | 2014 | o2hventures.com | Cambridge, United Kingdom | |
Online government services and information are provided to users. | 1707 | gov.uk | London, United Kingdom | |
Merger and acquisitions advisory firm | 1950 | canaccordgenuity.com | Toronto, Canada | |
CT Chris Torrance | Angel investor, ex-CEO of Pharmeasy, focused on healthcare and tech startups | unknown_d185ab8e01b54c4ba | ||
TJ Thomas Joseph Valentine | Angel investor and tech entrepreneur, co-founder of Secret Escapes, active in startups. | unknown_f9879fb9b9b140ea9 | ||
Psychedelic therapeutics for psychiatric disorders are developed and provided. | 2002 | cybin.com | Toronto, Canada |
Investor details for Small Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Small Pharma
5 dated milestones of Small Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Small Pharma is founded.
- Funding First funding round of $126K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $46.0M.
- Exit Acquired by Cybin.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Small Pharma
Complete news archive for Small Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Small Pharma
Small Pharma was founded in 2015.
Small Pharma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Small Pharma is a funded company, having raised a total of $49.17M across 7 funding rounds to date. The company's 1st funding round was a Seed of $125.67K, raised on Aug 2015.
Small Pharma has 9 employees.
Annual revenue of Small Pharma is $58.28K as on Feb 28, 2021.
Small Pharma was founded in 2015 in London, United Kingdom. Psychedelic-based therapeutics targeting mental health conditions are developed within the biotechnology sector. Tryptamine-based drug candidates are formulated using proprietary deuterium enriching technology. Operations center on advancing the pipeline, which includes SPL026, SPL028, SPL029, and SPL801 as injectable and oral DMT therapies for depressive disorder.
Small Pharma offers CYB003 and CYB004.
Small Pharma has 9 investors. Key investors include Gov.uk, Canaccord Genuity Group, Cybin, AI Fund, and o2h ventures.
The valuation of Small Pharma is $4.19M as of Jul 2019.
Small Pharma operates through Small Pharma Ltd.
Yes. Small Pharma was acquired by Cybin in August 2023.

